Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of MEDX's 30 holdings also in XDNA
43.5%
% of XDNA's 23 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 7.4% | 3.8% | 3.8% |
|
CRISPR THERAPEUTICS AG | 3.2% | 15.1% | 3.2% |
|
INTELLIA THERAPEUTICS, INC. | 2.0% | 8.7% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.2% | 1.6% | 1.6% |
|
BEAM THERAPEUTICS, INC. | 1.4% | 13.7% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to XDNA
|
ELI LILLY & CO | 16.0% |
|
AMGEN INC | 6.2% |
 |
NOVARTIS AG-ADR | 5.7% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% |
|
MERCK & CO. INC. | 4.7% |
|
JOHNSON & JOHNSON | 4.4% |
|
PFIZER INC | 4.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.8% |
|
ABBVIE INC | 3.6% |
|
BIOGEN IDEC INC | 3.4% |
MEDX Underweight Relative to XDNA
|
BEAM THERAPEUTICS, INC. | -12.3% |
|
CRISPR THERAPEUTICS AG | -11.9% |
|
THERMO FISHER SCIENTIFIC INC | -9.5% |
|
INTELLIA THERAPEUTICS, INC. | -6.7% |
|
PRIME MEDICINE, INC. | -5.9% |
|
EDITAS MEDICINE, INC. | -4.8% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
 |
SANOFI-AVENTIS | -3.2% |